Medical News

RSS

HearAtLast Holdings opens new tinnitus clinic in Canada

(PINKSHEETS: HRAL) HearAtLast Holdings, Inc., a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today that the Company is in the final development stage of a new Tinnitus Clinic located in the prominent Kingsway Community of Toronto, Ontario Canada.

22 Sep 2009

Results from a trial testing a 2009 H1N1 influenza vaccine in children look promising

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

22 Sep 2009

Book on raising competent and independent children

Parents are tired and frustrated by current methods of discipline and punishment offered in books and media today. Parents understand that they are living in “The Discipline Trap,” believing that discipline is something we do to our children rather than something we teach them.

22 Sep 2009

ART to report on its molecular imaging products research at the World Molecular Imaging Congress

ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that current research relating to its molecular imaging products will be presented at poster sessions at the World Molecular Imaging Congress (WMIC), being held at the Palais des congres in Montreal, Canada, from September 23 to 26, 2009.

22 Sep 2009

Three-year results of SPIRIT III clinical trial reaffirms safety of PROMUS and TAXUS Express stents

Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.

22 Sep 2009

Importance of residual thymopoiesis in aged adults

Doctor Manuel Leal is managing the Experimental Immune Virology Laboratory (in Virgen del Rocío University Hospital and Instituto de Biomedicina de Sevilla (IBIS), where clinic and basic science researchers work) where he leads a project to establish the functional nature of the thymus gland in adults. So far, it has been proven that this gland keeps on producing lymphocytes in the old age (Ferrando-Martínez et al. AGE, in press), which is a novelty because until very recently it was considered that this organ lost its immune capacity after the puberty.

22 Sep 2009

Bi-directional health information exchange to deal with disease outbreaks

Building upon four decades of research and real world operation of electronic medical records and health information exchange, Regenstrief Institute researchers have developed, tested and are now operating innovative technologies to allow for the bi-directional flow of evidence-based medical information between clinical sources and public health organizations.

22 Sep 2009

LSA's BCP in place to tackle demand for language assistance in the event of a potential swine flu pandemic

LSA (Language Services Associates), a leading provider of premium language-based solutions, today announced its comprehensive business continuity plan (BCP) for the 2009-2010 flu season. The strategy, which was devised by LSA’s BCP project management team, has been created to ensure the company is prepared for an increase in demand for language assistance in the event of a potential Swine Flu pandemic.

22 Sep 2009

Researcher can anticipate immune response in Alzheimer's patients

A researcher who is working on a vaccine for Alzheimer's disease (AD) has demonstrated that it is possible to test and measure specific immune responses in mice carrying human genes and to anticipate the immune response in Alzheimer's patients. This continuing research at Ben-Gurion University of the Negev could one day lead to specific Alzheimer's vaccines that reduce plaque, neuronal damage and inflammation associated with the disease.

22 Sep 2009

Lundbeck offers Sabril for treating children with infantile spasms in the U.S.

Lundbeck Inc. (“Lundbeck”), a wholly owned subsidiary of H. Lundbeck A/S in Denmark (Copenhagen: LUN), announced today that Sabril® (vigabatrin) Tablets and Powder for Oral Solution are now available for prescribing in the United States.

22 Sep 2009

New 3D/4D ultrasound system from MEDISON

MEDISON (CEO: Wongihl Sohn, www.medison.com), has announced the launch of a new dedicated high performance OB/GYN ultrasound system, featuring the industry's first multi-rendering 3D/4D technology, 3D MXI(TM) (3D Multi-eXtended Imaging(TM)) - ACCUVIX V20 'Prestige.'

22 Sep 2009

Wave Direct IF system launched by Celerus Diagnostics

Based on a strategy to deliver a broad range of assays for use on the Celerus Wave® System, Jason Lusk, Vice President of Sales and Marketing, today announced the availability of Wave Direct Immunofluorescence (IF).

22 Sep 2009

Update from Cannabis Science regarding its phytocannabinoid pharmaceutical products

Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report progress for its phytocannabinoid pharmaceutical products to help reduce ARDS-associated deaths from both the Avian and Swine Influenza infections.

22 Sep 2009

Ventus' PROVENT Sleep Apnea Therapy is runner-up at the The Wall Street Journal Technology Innovation Awards

Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that the company's PROVENT(R) Sleep Apnea Therapy received the Runners-Up Award in The Wall Street Journal 2009 Technology Innovation Awards, Medical Devices category. The results were published in the September 14, 2009 edition of The Wall Street Journal.

22 Sep 2009

DataSource partners with Rural Health to help customers secure grants for EHR projects

DataSource Mobility is committed to helping healthcare customers achieve their IT goals. As part of that commitment, they have extended their capabilities by partnering with Rural Health IT Corporation (Rural Health), to provide customers with assistance in securing grant funding for EHR projects up to $1.2 million.

22 Sep 2009

Transcatheter valve implantation is an effective treatment for patients with aortic stenosis

Research presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), demonstrated an "exceptionally low" rate of complications one year after implantation of transcatheter aortic valve prostheses.

22 Sep 2009

Biochemists are developing a new system to better understand antibiotic resistance

Rice University biochemists are developing a system of "evolutionary forecasting" to better understand the mechanisms of antibiotic resistance.

22 Sep 2009

New wireless Fractional Flow Reserve system to evaluate blood flow blockages in the arteries

St. Jude Medical, Inc. (NYSE: STJ) today announced the first use of the PressureWire™ Aeris technology, an interventional tool which measures Fractional Flow Reserve (FFR) to evaluate the severity of blood flow blockages in the arteries. This first-to-market technology helps interventional cardiologists better determine the ideal treatment option for their patients during coronary interventions, such as stent procedures.

22 Sep 2009

WHO emphasizes the importance of radon testing to prevent lung cancer

In simultaneous releases published around across the globe today, the World Health Organization (WHO) called for stronger action against indoor radon, the leading cause of lung cancer among U.S. and Canadian non-smokers.

22 Sep 2009

FBC Acquisition commences tender offer to acquire all outstanding shares of Facet Biotech

Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire all of the outstanding shares of Facet Biotech Corporation (NASDAQ:FACT) for $14.50 per share in cash, in furtherance of its previously announced acquisition proposal. The tender offer is scheduled to expire at 12:00 midnight, ET, on October 19, 2009, unless extended or terminated.

22 Sep 2009

Medical News

HearAtLast Holdings opens new tinnitus clinic in Canada

Results from a trial testing a 2009 H1N1 influenza vaccine in children look promising

Book on raising competent and independent children

ART to report on its molecular imaging products research at the World Molecular Imaging Congress

Three-year results of SPIRIT III clinical trial reaffirms safety of PROMUS and TAXUS Express stents

Importance of residual thymopoiesis in aged adults

Bi-directional health information exchange to deal with disease outbreaks

LSA's BCP in place to tackle demand for language assistance in the event of a potential swine flu pandemic

Researcher can anticipate immune response in Alzheimer's patients

Lundbeck offers Sabril for treating children with infantile spasms in the U.S.

New 3D/4D ultrasound system from MEDISON

Wave Direct IF system launched by Celerus Diagnostics

Update from Cannabis Science regarding its phytocannabinoid pharmaceutical products

Ventus' PROVENT Sleep Apnea Therapy is runner-up at the The Wall Street Journal Technology Innovation Awards

DataSource partners with Rural Health to help customers secure grants for EHR projects

Transcatheter valve implantation is an effective treatment for patients with aortic stenosis

Biochemists are developing a new system to better understand antibiotic resistance

New wireless Fractional Flow Reserve system to evaluate blood flow blockages in the arteries

WHO emphasizes the importance of radon testing to prevent lung cancer

FBC Acquisition commences tender offer to acquire all outstanding shares of Facet Biotech

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News